The CHA2DS2-VA score, derived by the removal of female sex from the CHA2DS2-VASc score, has recently been recommended for the prediction of ischemic stroke/systemic embolism (SSE) in patients with atrial fibrillation (AF).
Modification of the atrial unipolar electrogram (Uni-EGM) with loss of the near-field negative component in response to radiofrequency ablation reflects transmural loss of tissue conductivity.
Atrial fibrillation (AF) is common among sarcoidosis patients, with a prevalence of 29% and a 10-fold higher risk compared to the general population [1]. The…
Microneurography studies showed that the alpha-2 agonist clonidine suppresses sympathetic nerve activity (SNA). However, clonidine’s neuromodulation effects in ambulatory patients are unknown.
New-onset atrial fibrillation (NOAF), detected in the setting of acute non-cardiac illness, is a significant clinical concern in critically ill patients. The incidence rate of…
New-onset atrial fibrillation (NOAF) is associated with worse short-term prognosis among critically ill patients, and the benefit of anticoagulation is uncertain.
The use of transvenous cardiac implantable electronic devices (CIEDs) has continued to rise, paralleled by an increase in device-related infections. These infections are linked to…
The novel win ratio (WR) statistic has emerged as a promising alternative endpoint for the comparison of two treatment groups on multiple endpoints simultaneously, but…
Accessory pathway (AP) ablation is an established therapy for patients with Wolff-Parkinson-White (WPW) syndrome. An accurate 12-lead electrocardiogram (ECG) based identification of the AP location…
Focal ventricular arrhythmias (VA) arising from the anterior and posterior fascicles have been described. The anatomy of the anterior fascicle is variable,1,2 but the course…
Atrial fibrillation (AF) often coexists with heart failure (HF), exacerbating each other and worsening outcomes. Managing AF in HF patients is challenging, particularly in choosing…
